Our end-of-year wrap-up tradition – Oncology Brothers

Quoting Oncology Brothers on X/Twitter:

“Yet another busy year for FDA Oncology. ≥ 40 new approvals/indications in 2023 for Heme-Onc.

Our end-of-year wrap-up tradition. Indications and study findings for the 5 approved drugs in Lung Cancer:

Our end-of-year wrap-up tradition - Oncology Brothers

Source: Oncology Brothers/X